// App-Quantinova.ai

3422 : Novel E-Selectin Antagonist GMI-1271 Decreases Venous Thrombosis without Increased Bleeding Potential in a Mouse Model

Researchers

Presenter

  • Dorian L Culmer

Principal Investigators

  • Jose A. Diaz

  • Angela E. Hawley

  • Peter K. Henke

  • Suman L. Sood

  • Robert E Sigler

  • Andrea T Obi

  • John T. Patton

  • Thomas W. Wakefield

  • John L. Magnani

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • GlycoMimetics, Inc.

  • Research Essential S

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • E-selectin

Drug/Treatment

  • GMI1271

  • Enoxaparin sodium

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved